October 2024

Here's a recap of all the School of Medicine events that recently took place!

School of Medicine
UT Health RGV

News and Events

“Women in Medicine and Science Month” is celebrated throughout September. Each week this month will feature female faculty medical doctors and scientists from the UTRGV School of Medicine and UT Health RGV who are leading academic medicine, research, and education.

Read about Dr. Chelsea Chang here.

Read about Dr. Kelsey Baker here.

Read about Dr. Sheema Khan here.

Read about Dr. Maria de Jesus Muñoz here.

Read about Dr. Maria Villegas here.

Read about Dr. Cristel Escalona here.

Read about D. Beatriz Tapia here.

Read about Dr. Sara M. Reyna here.

Read about

Dr. Shizue Mito here.


Read about

Dr. Neeraj Chauhan here.

Read about Dr. Seratna Guadarrama-Beltran here.

September celebrates Women in Medicine and Science Month: 

UTRGV Valley physician brings innovative depression therapy to Valley patients


In Mexican culture, a "curandero" is a traditional healer known for using natural remedies and spiritual practices to treat ailments.


For Dr. Diana Chapa, chair of the Department of Neuro and Behavioral Health at the UTRGV School of Medicine and a psychiatrist at UT Health RGV, folk healing was her earliest exposure to medicine. Her grandfather was a curandero, and as she was growing up in a family of migrant farmworkers, she never imagined she would be where she is today.


Read more here.

September celebrates Women in Medicine and Science Month:

From South Texas to the East Coast


UTRGV School of Medicine former student, now at Harvard, shares how she is succeeding in medicine


Dr. Adriana Saavedra-Simmons, a 2022 graduate of the UTRGV School of Medicine, walks confidently down the pale hallways of Massachusetts General Hospital - Harvard Medical School, to visit with her patients.

 

A Valley native, she is now completing her third year as a resident physician as part of Harvard’s Internal Medicine Residency Program. She matched on the annual Match Day celebration on March 18, 2022, on the UTRGV Edinburg Campus.


Read more here.

UTRGV receives transformational $30 million grant to establish Diabetes Center of Excellence

Valley Baptist Legacy Foundation partners with UTRGV to combat diabetes crisis in the Rio Grande Valley


The Valley Baptist Legacy Foundation (VBLF) has awarded a significant $30 million grant to The University of Texas Rio Grande Valley to establish the UTRGV Diabetes Center of Excellence (UTRGV DCE).


The initiative, announced during a press conference on Monday, Sept. 16, 2024, will address the critical health crisis posed by the widespread prevalence of diabetes in the Rio Grande Valley.


The new center, which will be built near the UTRGV Institute of Neuroscience (ION) in Harlingen, is designed to combat diabetes through collaborative disease management, research and education.


Read more here.

Faculty & Staff Forum

Dean Michael Hocker hosted the School of Medicine's quarterly Faculty & Staff Forum, where he discussed updates on the school and UT Health RGV.

 

The meeting also discussed healthcare initiatives for the Valley, emphasizing our commitment to the success of our learners and how academic medicine is addressing the needs of the community through training future physicians, studying health diseases affecting the local population, and increasing access to quality primary and specialty care.

 

Key metrics included a 100% match rate for the Class of 2024, with 66% staying in Texas and of these 59% in the Rio Grande Valley.

 

The school achieved 93% GQ survey scores from the 2024 graduates, highlighting improved student satisfaction with the school's job of fostering and nurturing their development as future physicians. A new grant for cancer healthcare disparities research was announced, and attendees were reminded that the new cancer and surgery center is set to open in 2025.

 

Once a feasibility study is completed, the school plans to expand its class size to 100 students annually in a phased approach. It was also announced that UTRGV is on track to achieve Emerging Research University (ERU) status by 2028.

 

Thank you to all who joined in-person and virtually!

UTRGV School of Medicine signs new Kleberg Foundation Endowed Chair and Chief of Medical Oncology

The UTRGV School of Medicine, in continuing to uphold its promise to expand and elevate cancer care in the Rio Grande Valley and beyond, has signed its newest addition to the cancer care leadership team, Dr. Diane Duyen Nguyen.


Nguyen will join the UT Health RGV Cancer and Surgery Center as the Kleberg Foundation Endowed Chair and chief of the Division of Medical Oncology (cancer care) in October 2024, to lead, train and oversee the next generation of medical doctors and oncology physicians who are training and practicing at the UTRGV School of Medicine and UT Health RGV. 


Read more here.

Unsung Heroes:

Get to know some of the people who help make UTRGV run

Cristina Zapata, a Medical Simulation Specialist at UTRGV's Clinical Skills Center in Edinburg, plays a vital role in medical students' hands-on training. With eight years at UTRGV, she sets up task trainers, manages simulation recordings, and sometimes steps in as a Standardized Patient.


Zapata finds fulfillment in interacting with students and contributing to their learning experience. Her deep connection to UTRGV’s mission and the impact on the Rio Grande Valley drives her commitment to preparing future healthcare professionals.


Read more here.

UTRGV named ‘2024 Great College to Work For’

UTRGV continues to set the standard for excellence — not just in education, but also in creating a welcoming, supportive work environment.


This year, the university is recognized as one of the best places to work in higher education, according to the prestigious Great Colleges to Work For program. 


The results were released today, Friday, Sept. 20, in a special insert to The Chronicle of Higher Education, and are based on a survey of 216 colleges and universities. Only 75 institutions achieved “Great College to Work For” recognition for specific best practices and policies, placing UTRGV among a select group of top-performing schools in the country.


Read more here.

Celebrating Dr. H. Hidalgo

UT Health RGV hosted a retirement celebration for Dr. Humberto Hidalgo, pediatric pulmonologist at UT Health RGV, in honor of his over 30 years of dedicated service to the Rio Grande Valley.

 

During the event, Dr. Hidalgo was honored by City of Edinburg Mayor Ramiro Garza Jr., who issued a proclamation declaring "Dr. Hidalgo Day" in the City of Edinburg, recognizing his outstanding contributions and commitment to the community. Additionally, he was presented with an official flag flown at the U.S. Capitol on behalf of U.S. Representative Monica De La Cruz's office.

 

UT Health RGV commemorated Dr. Hidalgo's retirement with a special plaque celebrating his remarkable career and achievements. Surrounded by colleagues, Dr. Hidalgo was honored for his decades of service and dedication to healthcare in the Rio Grande Valley.


Dr. Hidalgo joined the UTRGV School of Medicine in October 2015 as an associate professor of Pediatrics and later served as the clinical vice chair of Pediatrics and was promoted to full professor. He was instrumental in developing the Cardiorespiratory Module and significantly impacted the curriculum and the training of future medical professionals.


Throughout his career, Dr. Hidalgo has made substantial research contributions, particularly in pediatric pulmonology and asthma management in Hispanic children. His dedication to teaching and leadership in various hospitals have earned him widespread recognition.


As Dr. Hidalgo moves into retirement, we sincerely thank him for his years of service and commitment. While he will be greatly missed, his legacy will continue inspiring future physicians and scholars.


We extend our best wishes to Dr. Humberto A. Hidalgo as he enters this new phase of his life!

Frontiers in Physiology

The collaborative research of Dr. Sara M. Reyna, assistant professor of

Human Genetics was recently published in the Journal of Frontiers in Physiology.


The publication is titled "Short-term HIIT impacts HDL function differently in lean, obese, and diabetic subjects." It examines the benefits of exercise training on coronary artery disease risk, showing that a 15-day short-term high-intensity interval training (HIIT) program reduces plasma cholesterol levels in type 2 diabetic subjects and fasting triacylglycerol levels in obese and type 2 diabetic subjects.


In addition, the HIIT program improves the antioxidant capacity of high-density lipoprotein (HDL) in lean, obese, and type 2 diabetic subjects and increases the cholesterol efflux capacity in lean subjects.


Overall, the research findings demonstrate that a short-term HIIT program is beneficial and sufficient to improve hyperlipidemia in obese and type 2 diabetic individuals, thus reducing coronary artery disease risk in these individuals.


Congratulations, Dr. Reyna!


Read more here.

International Materials Research Congress (IMRC) 2024

Dr. Subhash Chauhan and Dr. Murali Yallapu, faculty members of the UTRGV School of Medicine's South Texas Center of Excellence in Cancer Research, attended and presented at the International Materials Research Congress (IMRC) 2024, held in Cancun, Mexico.


This globally recognized conference is a key platform for researchers and scientists to share innovations and advancements in materials science, focusing on applications in medicine and biotechnology.


Dr. Chauhan presented his research on "Magnetic Nanoparticles and Protein Corona Interface for Cancer Therapeutic Applications," which explored the interface between magnetic nanoparticles and the protein corona that forms around them when introduced into the biological environment.


Dr. Yallapu delivered a presentation titled "Human Serum Albumin-Tannic Acid-Based Nanoparticles for Lung Cancer Therapy." His research focuses on developing nanoparticles utilizing human serum albumin and tannic acid as a delivery mechanism for targeted lung cancer therapy. 


The international research community highly regarded these presentations. Their work was recognized for its innovative approach to cancer therapy, positioning UTRGV as a leader in the intersection of materials science and medical research.


The IMRC 2024 provided a dynamic environment for networking with leading scientists and researchers.


UTRGVSOM students also attended IMRC 2024, where they actively participated by presenting their research posters and engaging in discussions with international experts. This opportunity allowed them to gain valuable insights into the latest advancements in materials science and its applications in medicine, furthering their academic and research development.


Thank you to those who participated!

Hidalgo County Employee Wellness Fair

UT Health RGV Family Medicine and Internal Medicine resident physicians were in attendance at the 2024 Hidalgo County Employee Wellness Fair.


These UT Health RGV residents gave Hidalgo County employees glucose screenings and blood pressure checks. They also provided information on UT Health RGV's Primary Care and Specialty services across the Valley to the event attendees.


Thank you to those who participated!

ICRS Symposium

Dr. Khalid Benamar, professor at the Department of Neurology and Behavioral Health at the UTRGV School of Medicine, and his team showcased their latest research at the 34th Annual International Cannabinoid Research Society (ICRS) Symposium in Salamanca, Spain.


The study highlighted the effectiveness and safety of Beta-Caryophyllene (BCP) and cannabidiol (CBD) in managing chronic inflammatory pain.


Dr. Benamar's team specifically investigated chronic neuropathic pain, a condition often resistant to current treatments. Their research aims to improve outcomes by exploring new therapeutic combinations and better understanding the neurobiology of pain.


Pictured are second-year medical students Hirma Garcia, Maria Sophia Malbas, Justin Mills, Joshua Nwose, and Briana Garcia; third-year students Emmanuel Franco and Zayd Ayas; research associates Sophia Leslie and Jose Rios; and Dr. Benamar. 


Congratulations!

Vaqueros MD / Luminary Scholars 2024

UTRGV recently welcomed a new cohort of 24 incoming freshmen to its prestigious UTRGV Luminary Scholars program, further highlighting the university's commitment to academic excellence.


The merit-based scholarship allows selected students to complete their education debt-free, removing financial barriers to higher education by covering all expenses associated with undergraduate, graduate, or professional degrees, and includes the UTRGV School of Medicine and the UTRGV School of Podiatric Medicine.


The third cohort of Luminary scholars welcomed eight students who will also be part of the Vaqueros MD Early Assurance Program. Students in this program were selected from a limited number of high-achieving South Texas students who begin their undergraduate career and receive conditional admission to the entering medical class at UTRGV School of Medicine upon graduation.


Read more here.

“Living Well with Blood Cancer”

UTRGV School of Medicine and UT Health RGV cancer care experts joined the Leukemia & Lymphoma Society (LLS) at “Living Well with Blood Cancer,” an event designed to share information on how blood cancer treatment and care advancements are benefitting the Rio Grande Valley.

 

The Valley historically has had limited access to specialized cancer care. Now, through the UT Health RGV Cancer and Surgery Center, slated to open in 2025, specialized cancer care will offer the treatments Valley patients need without the need to travel.

 

Nationwide, blood cancers such as leukemia, lymphoma, and myeloma account for about 10% of all cancer diagnoses, with more than 190,000 new cases expected in 2024 alone, according to the American Cancer Society.

 

Dr. Everardo Cobos – medical oncologist and hematologist at UT Health RGV; chair of the Department of Medicine and Oncology at the UTRGV School of Medicine; and director of the Cancer Service Line at the Cancer and Surgery Center – and Daniel Hernandez, manager of Oncology Pharmacy Services at the Cancer and Surgery Center, shared their expertise on the latest developments in cancer care.


Thank you for your participation, Dr. Cobos and Mr. Hernadez!

Thank you Futuro RGV for supporting our students!

Futuro McAllen/ Futuro RGV began as an advocacy citizen group in 1999 to address Quality-of-Life issues that were in danger of being sidetracked due to tremendous growth. Futuro stressed a positive approach of identifying the issue, recommending, and presenting a solution to the agency—usually the City Commission—that had the authority to make the change.

 

These Quality-of-Life issues included community safety, health, education, security of good jobs and homes, recreation, culture, and arts. It is also committed to providing impartial and nonpartisan information on quality-of-life issues affecting local communities, including quality economic growth, educational opportunities, healthy families, safe neighborhoods, green space, culture, and the arts.

 

Futuro RGV has committed to donating a White Coat to a deserving student for the last four years as part of these commitments to the region. They recently began supporting two white coat students for the past two years, as Dr. Nedra Kinerk, president of Futuro RGV, began to donate one jacket on her own.


They recognize UTRGV School of Medicine students as future community leaders, and that is why they invite and recognize them at their annual RGV Leadership event. 


Congratulations!


2024 Texas Society of Clinical Oncology Conference

Dr. Edgar G. Dorsey-Treviño, MMSc, PGY-1 in Internal Medicine at Knapp Medical Center, has been accepted to showcase his research for a poster presentation at the prestigious 2024 Texas Society of Clinical Oncology Conference, to be held in San Antonio, TX. Additionally, he has been honored with a travel award to attend the conference.


In his project, titled "Long-Term Efficacy of High-Dose Imatinib in Hispanic Patients Without Access to Second-Generation Tyrosine Kinase Inhibitors Treated in LATAM Centers," Dorsey-Treviño and his colleagues explored outcomes in chronic myeloid leukemia (CML) patients. Their findings suggest that for patients who did not initially respond to standard-dose imatinib, increasing the dosage produced outcomes comparable to those seen with newer medications, offering hope for patients in resource-limited settings.


Reflecting on this achievement, Dorsey-Treviño shared that he is "deeply honored to present our work at such a renowned conference. This milestone brings me closer to my aspiration of becoming a physician-scientist in hematology/oncology, and I hope our research will make a meaningful impact."


Congratulations, Dr. Dorsey-Treviño!


NASA Solar System Ambassador Dr. Thomas B. Spencer Interviews UTRGV’s Dr. Seratna Guadarrama Beltran on Space Microbiology

NASA Solar System Ambassador and UTRGV Associate Vice President for Research Operations, Dr. Thomas B. Spencer, recently conducted an insightful online discussion with Dr. Seratna Guadarrama Beltran, an expert in space microbiology at The University of Texas Rio Grande Valley (UTRGV). The conversation covered Dr. Guadarrama Beltran’s groundbreaking research, its impact on space exploration, and opportunities for students to grow their careers in space sciences.


Spencer opened the interview by introducing Guadarrama Beltran and highlighting the significance of her work, stating, “She is going to be talking about some of her amazing work and how it affects space sciences, and even better, how it can grow the careers of some students.”


Guadarrama Beltran began by outlining her primary area of expertise: “My area of expertise is found within the field of space microbiology, and my primary research is focused on how bacterial pathogens respond to environmental stressors, including altered gravity or spaceflight conditions.” She has worked extensively with bacteria and human cells under microgravity and other stressors.


Read more here.

Congratulations, Dr. S. Williams-Blangero and Dr. T. Howard!

Congratulations to Drs. Tom Howard and Sarah Williams-Blangero from the UTRGV School of Medicine's Department of Human Genetics. They recently received a grant award of $2,701,976 from the National Heart, Lung, and Blood Institute of NIH. The four-year project entitled "Omics Approaches to Factor VIII Inhibitor Development in Hemophilia Patients of Mexican Descent" started on Sept. 1, 2024, and will run through June 30, 2028.

 

Congratulations again!

Outstanding Hematology/Oncology Trainee Award

Congratulations to Dr. Edgar G. Dorsey-Treviño, MMSc, PGY-1 in Internal Medicine at Knapp Medical Center, whom the Texas Society of Clinical Oncology has selected for the "Outstanding Hematology/Oncology Trainee Award."


Dr. Dorsey-Treviño's research—titled "Long-Term Efficacy of High-Dose Imatinib in Hispanic Patients Without Access to Second-Generation Tyrosine Kinase Inhibitors Treated in LATAM Centers"—will be showcased at the prestigious 2024 Texas Society of Clinical Oncology Conference, to be held in San Antonio, TX. Additionally, he has been honored with a travel award to attend the conference.


Congratulations, Dr. Dorsey-Treviño!

Student Spotlight

Meet UTRGV MS2, Chantal Uzoma

The UTRGV School of Medicine is a practicing academic medical institution. What aspect of Academic Medicine impacts you the most?



The educational aspect of Academic Medicine impacts me the most. Like with anything, a physician is only as good as its foundation. The interactions we have and the skills we learn from our mentors and seasoned physicians are indicative of what kind of physicians we will become.   



Learn more about Uzoma here.

Faculty Focus

Academic Medical Minute with:

Fatimah Oluwakemi Bello, MD

Assistant Professor of Medicine/ UTRGV-Knapp Internal Medicine Program Director

When did you join the UTRGV School of Medicine?

I joined UTRGV School of Medicine in June 2017 as a resident physician and became a faculty member in July 2020. 


What brought you here?

I fell in love with the RGV when I came to an interview at UTRGV-DHR in Jan. 2017. The area had many similarities to the town where I grew up in my home country (Nigeria), and I saw many potentials and opportunities for my growing family and career. I also saw that the area is genuinely underserved and that I can make a difference here. Fortunately, I was matched to the program, moved here, and am glad to call the RGV home now. 

 

What do you enjoy about working in academic medicine?

In addition to making a meaningful impact on patients and their families, I enjoy the intellectually stimulating environment and the opportunity to contribute to science and participate in life-changing research studies. I also genuinely love working with the residents, and I always remain very grateful for the opportunity to contribute in my own little way to shaping the next generation of physicians.  


Why is academic medicine important to our community?

Academic medicine is crucial to the RGV for several reasons. It will help integrate the latest research and evidence-based practices into patient care, which this historically underserved area needs. It also provides a platform for training the next generation of healthcare professionals. More importantly, academic medicine in the RGV will lead to various community-based initiatives specifically designed for the RGV, further promoting culturally competent stellar care.  


How do you spend your free time? I enjoy spending time with my husband and my very energetic kids. I also really enjoy volunteering as a means of giving back, making a tangible difference in people's lives, and achieving personal fulfillment.

UTRGV Newsroom

UT Health RGV pediatrician offers health tips for back-to-school season

UTRGV welcomes third cohort of Luminary Scholars

UT Health RGV cancer experts speak at community educational event – ‘Living Well with Blood Cancer’

UT Health RGV cancer experts share blood cancer care advances

UTRGV researchers developing drugs to fight pancreatic and prostate cancer

In the News

Valley Native Bringing Advanced Oncology Services To UT Health RGV Cancer and Surgery Center

Medical Schools and Health Systems Receive $400,000 to Enhance Patient Trust

Bringing a human rights focus to humanitarian work

Ayuda para pacientes con diabetes

Baptist Health Women’s Clinic-Fort Smith Adds Two Physicians

New pediatric hospital provides greater access in RGV, but challenges remain for South Texas families

UTRGV receives $30M grant to combat diabetes in Valley

UT Rio Grande Valley receives $30 million for diabetes center

A South Texas region finally gets a children’s hospital, but many families still can’t find care

UTRGV receives $30M grant to combat diabetes in Valley

Research Corner

Hypercalcemia-Driven Spontaneous Tumor Lysis Syndrome in a Case of Recently Diagnosed Multiple Myeloma: An Unusual Clinical Encounter

Is This the Key to Beating Pancreatic Cancer? The Game-Changing Gene Identified by Indian Scientist

Click below to see School of Medicine and University-wide events.
SOM Events Calendar
The University of Texas
Rio Grande Valley School of Medicine
Phone: (956) 296-1900
Contact Us
Facebook  Twitter